Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $801 at Truist 'To Refresh Risk/Reward'

March 31, 2026 7:04 AM
(Updated - March 31, 2026 9:41 AM EDT)

Truist Securities analyst Greg Renza lowered the price target on Regeneron ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change